Form D · Other

SEMPRAE LABORATORIES INC

Saddle Brook, NJ · CIK 0001446904

Offering snapshot reported Dec 21, 2010 · SEC filing

Reported sold
$4.1M
Offering amount: $10.1M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 7, 2010
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 21, 2010Initial$4,100,000No comparison3SEC filing
Oct 4, 2010Initial$1,000,000No comparison1SEC filing
Feb 3, 2010Initial$3,106,000No comparison9SEC filing
Sep 26, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-152302

Source: Form D, filed Dec 21, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Lucinda Holt Director
Mary Wallace Jaensch Director, Executive
Stacie Mullen Director
Adele C. Oliva Director
Camille Samuels Director
Rachel Braun Scherl Director, Executive

Issuer details

Industry: Other (See others in industry)

Address:
160 Pehle Avenue Park 80 East, Suite 301
Saddle Brook, NJ, 07663